Biosimilar (Insulin) Competitive Landscape and Market & Pipeline Insights, 2015

DelveInsight, the leading market research and consulting company has added a new report “Biosimilar (Insulin) Competitive Landscape and Market & Pipeline Insights, 2015” to its portfolio.
By: DelveInsight Business Research
 
NEW DELHI - Nov. 17, 2015 - PRLog -- DelveInsight, the leading market research and consulting company has added a new report “Biosimilar (Insulin) Competitive Landscape and Market & Pipeline Insights, 2015” to its portfolio. In addition to this, our research expertise provides the clients with up to date information of market till the date of order.

The Biosimilar (Insulin) Competitive Landscape and Market & Pipeline Insights, 2015 report provides the client with details on the ongoing enterprises and the upcoming business opportunities related to new interventions. It comprehensively includes:

· 10+ pipeline drugs with 5+ companies actively involved in drug development. There are 3 drugs in phase III, 1 in phase I, 6 in pre-clinical 1 in discovery and 1 dormant.

· R&D activities and technologies used along with the pipeline molecules in development.

· Therapeutic assessments by molecule types, route of administration, monotherapy and combination products.

· Information related to collaborations, in-licensing and out-licensing deals.

DelveInsights, Biosimilar (Insulin) Competitive Landscape and Market & Pipeline Insights, 2015 report provides the in-depth analysis of Biosimilar (Insulin) - Competitive Landscape across the globe. Therefore the report on Biosimilar (Insulin) Competitive Landscape and Market & Pipeline Insights, 2015 provides information on chemical technology and comparative analysis at various stages. In addition, it helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight is offering the Report at a price of USD 1,450 as a single user license, USD 2,900 as a site license and USD 4,000 as a Global/Enterprise License.

For more information on Biosimilar (Insulin) Competitive Landscape and Market & Pipeline Insights, 2015 report, email at info@delveInsight.com

About Us

DelveInsight is a leading Business Consulting and Market Research Firm. They help clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.

Contact
DelveInsight Business Research
New Delhi-110075, I
***@delveinsight.com
End
Source:DelveInsight Business Research
Email:***@delveinsight.com Email Verified
Tags:Insulin Biosimilar Phase III, Insulin Biosimilar Phase I, Insulin Biosimilar Preclinical
Industry:Business
Location:New Delhi - Delhi - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
DelveInsight News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share